针对HBsAg血清清除的新兴疗法:聚焦新型组合策略
Rex Wan-Hin Hui1, James Fung1,2, Wai-Kay Seto1,2
1Department of Medicine, Queen Mary Hospital, The University of Hong Kong, Pokfulam Road, Pok Fu Lam, Hong Kong.
Hepatology international
|June 10, 2025
概括
新型组合疗法显示出在慢性乙型肝炎 (CHB) 中实现功能治愈的前景. 将RNA沉声器与免疫调节剂结合起来,可以增强HBsAg的衰减和免疫恢复,从而改变CHB的管理.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
背景情况:
- 目前用于慢性乙型肝炎 (CHB) 的治疗方法很少实现功能治愈.
- 针对病毒和免疫系统的新药正在开发中.
- 焦点正在转向组合策略,以改善CHB治疗结果.
研究的目的:
- 审查CHB的新型组合治疗策略.
- 讨论CHB治疗的潜在机制和未来方向.
主要方法:
- 对CHB的新型组合策略的数据进行全面审查.
- 分析RNA沉声器 (反意义寡核酸,小干扰RNA) 作为组合的支柱.
- 评估与免疫调节剂的协同效应.
主要成果:
- 与免疫调节剂相结合的RNA静音剂增强了乙型肝炎表面抗原 (HBsAg) 的下降,并延长了治疗效果.
- 组合疗法可以减少治疗后的HBsAg反弹.
- 显著的HBsAg降低与基于RNA沉默器或基于免疫检查点抑制剂的疗法患者的免疫功能障碍恢复有关.
结论:
- 通过新的组合治疗方法,可以实现CHB的功能治疗.
- 优化组合疗法和个性化治疗对于未来的CHB管理至关重要.
- 新的组合策略有可能彻底改变CHB护理.
关键词:
在ASO的基础上,ASO是ASO.组合组合是一种组合.这就是HBV HBV.这就是HBsAg.在HCC中,HCC是HCC.免疫检查点抑制剂 免疫检查点抑制剂免疫调节剂是一种免疫调节剂.在T细胞,T细胞.疫苗 疫苗 疫苗 疫苗siRNA 是一个RNA.更多相关视频
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
2.2K
12:09Use of Single Chain MHC Technology to Investigate Co-agonism in Human CD8+ T Cell Activation
Published on: February 28, 2019
9.7K
相关概念视频
Retrovirus Life Cycles
45.7K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
45.7K
Hybridoma Technology
14.1K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
14.1K
